339 related articles for article (PubMed ID: 12442118)
1. [Intravenous immunoglobulins in dermatology].
Nydegger U; Hunziker T
Ann Dermatol Venereol; 2002; 129(8-9):1078-81. PubMed ID: 12442118
[No Abstract] [Full Text] [Related]
2. The use of i.v. IG therapy in dermatology.
Fernandez AP; Kerdel FA
Dermatol Ther; 2007; 20(4):288-305. PubMed ID: 17970894
[TBL] [Abstract][Full Text] [Related]
3. [Use of intravenous immunoglobulin preparations (IVIG) in treatment of primary cell immunodeficiencies].
Siwińska-Gołebiowska H; Czerwińska-Kartowicz I; Markiewicz K
Postepy Hig Med Dosw; 2002; 56 Suppl():33-40. PubMed ID: 12661412
[TBL] [Abstract][Full Text] [Related]
4. Clinical uses of intravenous immunoglobulin.
Jolles S; Sewell WA; Misbah SA
Clin Exp Immunol; 2005 Oct; 142(1):1-11. PubMed ID: 16178850
[No Abstract] [Full Text] [Related]
5. Treatment of toxic epidermal necrolysis with intravenous immunoglobulin.
Simeone F; Rubio ER
J La State Med Soc; 2003; 155(5):266-9. PubMed ID: 14748489
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin therapy: the process, the product, the patient, and the pocketbook. Introduction.
Harvey RD
Pharmacotherapy; 2005 Nov; 25(11 Pt 2):71S-72S. PubMed ID: 16229676
[No Abstract] [Full Text] [Related]
7. The use of intravenous immunoglobulin for treatment of dermatological conditions in Australia: A review.
Smith SD; Dennington PM; Cooper A
Australas J Dermatol; 2010 Nov; 51(4):227-37. PubMed ID: 21198517
[TBL] [Abstract][Full Text] [Related]
8. Intravenous immunoglobulin in toxic epidermal necrolysis.
Pasic S
Int J Dermatol; 2006 Sep; 45(9):1117-8. PubMed ID: 16961531
[No Abstract] [Full Text] [Related]
9. Toxic epidermal necrolysis treated with intravenous immunoglobulin and granulocyte colony-stimulating factor.
Kalyoncu M; Cimsit G; Cakir M; Okten A
Indian Pediatr; 2004 Apr; 41(4):392-5. PubMed ID: 15123870
[TBL] [Abstract][Full Text] [Related]
10. The patient: Emerging clinical applications of intravenous immunoglobulin.
Harvey RD
Pharmacotherapy; 2005 Nov; 25(11 Pt 2):85S-93S. PubMed ID: 16229679
[TBL] [Abstract][Full Text] [Related]
11. Supply, use, and abuse of intravenous immunoglobulin.
Nowak-Wegrzyn A; Lederman HM
Curr Opin Pediatr; 1999 Dec; 11(6):533-9. PubMed ID: 10590912
[TBL] [Abstract][Full Text] [Related]
12. [Intravenous inmunoglobulins in pediatrics].
Panadero Esteban MI; Carcelén Andrés J; Urbieta Sanz E; Viñuales Armengol MC; Idoipe Tomás A
Farm Hosp; 2003; 27(3):179-87. PubMed ID: 12835820
[TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulin for the treatment of toxic epidermal necrolysis.
Trent JT; Kerdel FA
Arch Dermatol; 2003 Aug; 139(8):1081. PubMed ID: 12925403
[No Abstract] [Full Text] [Related]
14. Novel mechanism for therapeutic action of IVIg in autoimmune blistering dermatoses.
Michael D; Grando SA
Curr Dir Autoimmun; 2008; 10():333-43. PubMed ID: 18460894
[TBL] [Abstract][Full Text] [Related]
15. [Toxic epidermal necrolysis. Therapy in ICU with intravenous immunoglobulins in a case].
Andresen M; Boghero Y; Molgó M; Dougnao A; Díaz O
Rev Med Chil; 2000 Dec; 128(12):1343-8. PubMed ID: 11227243
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulin: an emerging treatment for immune-mediated skin diseases.
Rütter A; Luger TA
Curr Opin Investig Drugs; 2002 May; 3(5):713-9. PubMed ID: 12090544
[TBL] [Abstract][Full Text] [Related]
17. [Therapy recommendations for the use of intravenously applicable immunoglobulins].
Marschner JP; Rietbrock N
Med Klin (Munich); 1996 Mar; 91(3):141-7. PubMed ID: 8628200
[No Abstract] [Full Text] [Related]
18. Off-label uses of biologics in dermatology: interferon and intravenous immunoglobulin (part 1 of 2).
Smith DI; Swamy PM; Heffernan MP
J Am Acad Dermatol; 2007 Jan; 56(1):e1-54. PubMed ID: 17190617
[TBL] [Abstract][Full Text] [Related]
19. Use of high-dose immunoglobulins in dermatology.
Enk A; Fierlbeck G; French L; Hertl M; Messer G; Meurer M; Steinbrink K; Stingl G; Volc-Platzer B; Zillikens D
J Dtsch Dermatol Ges; 2009 Sep; 7(9):806-812. PubMed ID: 19624804
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin: properties, mode of action and practical use in dermatology.
Prins C; Gelfand EW; French LE
Acta Derm Venereol; 2007; 87(3):206-18. PubMed ID: 17533485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
